DL-3-Aminobutyric acid

DL-3-Aminobutyric acid is a four-carbon amino acid featuring a chiral center at C-3 in the 3-aminobutyric acid framework, supplied as a racemic DL mixture. The molecule contains a primary amino group and a carboxylic acid, enabling salt formation, acid-base tuning, and direct participation in amide and peptide-bond forming chemistry after appropriate activation. Side-chain reactivity is dominated by the amino functionality, while the aliphatic backbone supports derivatization into esters, amides, and protected amino acid intermediates. As a chiral amino acid precursor in racemic form, it can be used to build 3-aminobutyric acid motifs in peptide-like structures, enzyme substrate analogs, and synthetic intermediates for downstream stereochemical resolution or conversion to enantiopure derivatives.

1. Peptide Synthesis

DL-3-Aminobutyric acid is used in peptide coupling workflows where a 3-aminobutyric acid residue is required as an aliphatic building block. The carboxylic acid and primary amine enable formation of peptide-like amide linkages after conversion to an activated acid derivative or protected amino acid ester, while the racemic stereocenter can be carried through to generate defined diastereomeric outcomes in subsequent steps. N- or C-protection strategies such as temporary amine protection and carboxyl activation support compatibility with standard peptide coupling chemistries used for short peptide analogs and peptidomimetic scaffolds. Incorporation of the 3-aminobutyric acid motif can support structure-activity relationship studies that probe backbone length and side-chain electronics in amino acid substitution patterns.

2. Amino Acid Derivatization

DL-3-Aminobutyric acid serves as a direct starting material for amino acid derivatization into esters, amides, and functionalized intermediates used in fine chemical synthesis. The primary amino group can undergo acylation, sulfonylation, or carbamate formation to introduce stable protecting groups for controlled coupling sequences, while the carboxyl group can be esterified to improve solubility and enable downstream transformations. Racemic incorporation is suitable for generating libraries of substituted derivatives where stereochemical purity is not the primary variable, or where later resolution is planned. Downstream utility includes preparation of N-protected 3-aminobutyric acid derivatives, lactam-forming precursors, and amide-linked intermediates that feed into larger molecular assemblies.

3. Chiral Building Block Development

DL-3-Aminobutyric acid can be employed in chiral synthesis routes as a racemic chiral amino acid intermediate that may be converted into enantiopure materials through resolution or stereoselective transformations. The stereogenic center at C-3 allows formation of diastereomeric salts or derivatives when paired with chiral resolving agents, enabling separation strategies prior to peptide building block preparation. Protecting-group selection for the amino and carboxyl functionalities can be tailored to maintain stereochemical integrity during resolution and subsequent coupling steps. Resulting enantiopure 3-aminobutyric acid derivatives can then be used for stereochemically defined peptide analogs, chiral auxiliaries, and structure-guided synthetic methodology development.

4. Chemical Biology Reagents

DL-3-Aminobutyric acid is applicable to chemical biology research where amino acid analogs are used to probe transport, metabolism, or enzyme recognition of 3-aminobutyric acid-like motifs. The combination of a primary amine and carboxyl group supports conjugation and labeling strategies after derivatization into activated esters, amide-forming intermediates, or protected handles for controlled coupling to biomolecule scaffolds. Racemic material can be used for initial screening of binding or incorporation behavior, with stereochemical refinement possible when enantiopure analogs are required. Downstream derivatives can function as biochemical research intermediates for generating peptide fragments, substrate analogs, and analytical probes that support mechanistic studies in amino acid processing pathways.

5. Pharmaceutical Intermediate Preparation

DL-3-Aminobutyric acid is suitable for pharmaceutical intermediate preparation in synthetic routes that require an aliphatic amino acid unit for medicinal chemistry and process chemistry. The amino acid functionality supports conversion into protected amino acid derivatives that can be incorporated into amide-containing intermediates, including side-chain modified scaffolds and peptidomimetic fragments. Carboxyl activation and amine protection enable controlled sequencing in multistep syntheses, while the racemic nature can be accommodated in early route development prior to later stereochemical optimization. Generated intermediates can be carried forward to produce larger drug-like molecules featuring 3-aminobutyric acid motifs and to support manufacturing-oriented synthesis planning for amino acid-derived building blocks.

1. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

2. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats